Danaher's Q3 Earnings Beats Street Estimates

Loading...
Loading...
  • Danaher Corporation DHR logged Q3 adjusted EPS of $2.39 up 39% Y/Y, surpassing the estimate of $2.15.
  • Sales increased 23% to $7.2 billion, with 20.5% non-GAAP core revenue growth, beating the $7.00 billion estimate.
  • Year-to-date operating cash flow was $6.0 billion, representing a 51% increase and non-GAAP free cash flow was $5.2 billion, +46.5%.
  • The gross margin expanded to 60.3% from 54.8% a year ago, operating margin compressed slightly to 18.1% from 18.8.
  • Outlook: For Q4 FY21, Danaher anticipates core revenue growth of the low-to-mid teens percent range.
  • For FY21, the core revenue growth rate remains unchanged at 20%.
  • Price Action: DHR shares are down 4.71% at $300 during the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...